Medical device maker Medtronic Plc on Tuesday projected revenue rose to $7.3 billion in the fourth quarter, its first to include results from Covidien Plc, and earnings would be at the upper end of its previously forecast range.
Analysts on average were expecting revenue of $7.08 billion, according to Thomson Reuters I/B/E/S.
Medtronic said fourth-quarter cash earnings, excluding charges, would be in the upper half of a range of $1.08 to $1.13.
The preliminary quarterly results were the first to include revenue generated by Covidien Plc, which Medtronic acquired in January for $49.9 billion.
Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
Latest stories
Related stories
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
